With increasing numbers of patients needing intensive care or who are immunosuppressed,
infections caused by moulds other than Aspergillus spp or Mucorales are increasing …

Continued advancement of medical science offers life-saving treatment options for a variety
of hematologic, oncologic, and rheumatologic conditions. Immunosuppression, a common …

Mycoses summarized in the hyalohyphomycosis group are heterogeneous, defined by the
presence of hyaline (non‐dematiaceous) hyphae. The number of organisms implicated in …

Melanized or dematiaceous fungi are associated with a wide variety of infectious
syndromes. Many are soil organisms and are generally distributed worldwide, though …

Despite advances in preventive, diagnostic, and therapeutic interventions, invasive fungal
infections cause significant morbidity and mortality in immunocompromised patients. The …

Scedosporium spp. are increasingly recognized as causes of resistant life-threatening
infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum …

The frequency of invasive mycoses due to opportunistic fungal pathogens has increased
significantly over the past two decades (35, 74, 83, 88, 89, 101, 106). This increase in …

Patient characteristics, antifungal prophylaxis, and other factors appear to have contributed
to a change in the spectrum of invasive fungal pathogens. Infections with Candida glabrata …

Invasive fungal diseases (IFDs) are an increasingly common complication in critically ill
patients in Europe and are frequently fatal. Because of changes in treatment strategies and …

The in vitro activity of the novel triazole antifungal agent posaconazole (Noxafil; SCH 56592)
was assessed in 45 laboratories against approximately 19,000 clinically important strains of …